| Network medicine framework for identifying drug-repurposing opportunities for COVID-19 D Morselli Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, ... Proceedings of the National Academy of Sciences 118 (19), e2025581118, 2021 | 491 | 2021 |
| Integration of molecular interactome and targeted interaction analysis to identify a COPD disease network module A Sharma, M Kitsak, MH Cho, A Ameli, X Zhou, Z Jiang, JD Crapo, ... Scientific reports 8 (1), 14439, 2018 | 45 | 2018 |
| Mechanical forces induce an asthma gene signature in healthy airway epithelial cells A Kılıç, A Ameli, JA Park, AT Kho, K Tantisira, M Santolini, F Cheng, ... Scientific reports 10 (1), 966, 2020 | 44 | 2020 |
| Clinical validation of a blood-based predictive test for stratification of response to tumor necrosis factor inhibitor therapies in rheumatoid arthritis patients T Mellors, JB Withers, A Ameli, A Jones, M Wang, L Zhang, HN Sanchez, ... Network and Systems Medicine 3 (1), 91-104, 2020 | 41 | 2020 |
| Whole exome sequencing analysis in severe chronic obstructive pulmonary disease D Qiao, A Ameli, D Prokopenko, H Chen, AT Kho, MM Parker, J Morrow, ... Human molecular genetics 27 (21), 3801-3812, 2018 | 39 | 2018 |
| Network medicine framework for identifying drug repurposing opportunities for COVID-19. ArXiv DM Gysi, I Do Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ... arXiv preprint arXiv:2004.07229, 2020 | 15 | 2020 |
| Network medicine framework for identifying drug repurposing opportunities for COVID-19. arXiv 2020 DM Gysi, ÍD Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ... arXiv preprint arXiv:2004.07229, 2004 | 11 | 2004 |
| Method of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based on a trained machine learning classifier SD Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ... US Patent 11,195,595, 2021 | 5 | 2021 |
| Network medicine framework for identifying drug repurposing opportunities for covid-19 (2020) DM Gysi, Í Do Valle, M Zitnik, A Ameli, X Gan, O Varol, H Sanchez, ... arXiv preprint arXiv:2004.07229 10, 2004 | 5 | 2004 |
| Methods of treating a subject suffering from rheumatoid arthritis based in part on a trained machine learning classifier S Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ... US Patent 11,456,056, 2022 | 3 | 2022 |
| Network Medicine Framework for Identifying Drug Repurposing Opportunities DM Gysi, AL Barábasi, IF Do Valle, O Varol, X Gan, A Ameli, J Loscalzo, ... US Patent App. 17/456,519, 2022 | 3 | 2022 |
| Methods of treating a subject suffering from rheumatoid arthritis with anti-tnf therapy based in part on a trained machine learning classifier S Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ... US Patent App. 18/753,994, 2024 | | 2024 |
| Methods of treating a subject suffering from rheumatoid arthritis with anti-TNF therapy based in part on a trained machine learning classifier S Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ... US Patent 12,062,415, 2024 | | 2024 |
| Methods of treating a subject suffering from rheumatoid arthritis with alternative to anti-TNF therapy based in part on a trained machine learning classifier S Ghiassian, TR Mellors, M Santolini, A Ameli, N Schoenbrunner, ... US Patent 11,783,913, 2023 | | 2023 |
| Network Medicine Approaches to Diagnostics and Therapeutics A Ameli Northeastern University, 2020 | | 2020 |
| Exploiting the structure of temporal networks to identify the keys genes in diseases A Ameli, Z Jabalameli, M Santolini, A Kho, S Weiss, A Sharma NetSci, 2017 | | 2017 |
| Predicting protein-protein interactions with latent geometry M Kitsak, R Aldecoa, I Voitalov, A Ameli, A Sharma, N Johnson, A Dhroso, ... NetSci, 2017 | | 2017 |